Filtros de búsqueda

Lista de obras de

1004 The value of external beam radiation in pathologic node positive prostate cancer: A multivariate analysis

scholarly article

1055 Prostate cancer: Estimating long-term rectal bleeding risk using dose-volume histograms ⬇️

artículo científico publicado en 1995

141 Overall survival and local control following combined modality therapy and selective bladder preservation for invasive bladder cancer ⬇️

artículo científico publicado en 1996

203 Bladder cancer: The combination of chemotherapy and irradiation in the treatment of patients with muscle-invading tumors

scholarly article

2053 Probability of subsequent failure in men with prostate cancer clinically disease free 10 years after treatment with radiation therapy

scholarly article

A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0

article

A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902.

artículo científico publicado en 2015

Acute and Late Toxicity After Dose Escalation to 82 GyE Using Conformal Proton Radiation for Localized Prostate Cancer: Initial Report of American College of Radiology Phase II Study 03-12 ⬇️

artículo científico publicado el 6 de octubre de 2010

Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01.

artículo científico publicado en 2016

Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.

artículo científico publicado en 2005

Adjuvant radiation therapy for early stage seminoma: Proton versus photon planning comparison and modeling of second cancer risk ⬇️

artículo científico publicado el 3 de marzo de 2012

Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter

scientific article published on 01 October 2004

Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality

artículo científico publicado en 2019

Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer

scientific article published on 26 March 2020

Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer

artículo científico publicado en 2006

Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.

artículo científico publicado en 2007

Benchmarks achieved in the delivery of radiation therapy for muscle-invasive bladder cancer

artículo científico publicado en 2007

Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis

artículo científico publicado en 2006

Bladder Preservation Therapy for Muscle-Invading Bladder Cancers on Radiation Therapy Oncology Group Trials 8802, 8903, 9506, and 9706: Vascular Endothelial Growth Factor B Overexpression Predicts for Increased Distant Metastasis and Shorter Survival ⬇️

artículo científico publicado el 31 de mayo de 2013

Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial.

artículo científico publicado en 2018

Bladder cancer

artículo científico publicado en 2009

Bladder cancer

artículo científico publicado en 2009

Bladder cancer

artículo científico publicado en 2013

Bladder cancer. Clinical guidelines in oncology

artículo científico publicado en 2006

Bladder cancer. Clinical practice guidelines in oncology

artículo científico publicado en 2005

Bladder preservation strategies

artículo científico

Bladder preservation: optimizing radiotherapy and integrated treatment strategies

artículo científico publicado en 2008

Bladder-sparing approaches to invasive disease

artículo científico publicado en 2006

COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial

artículo científico publicado en 2007

Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08.

artículo científico publicado en 2015

Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202

artículo científico publicado en 2024

Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.

artículo científico publicado en 2008

Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.

artículo científico publicado en 2008

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 3-2004. A 57-year-old man with invasive transitional-cell carcinoma of the bladder

artículo científico publicado en 2004

Celebrating 40 years of clinical inquiry: The RTOG'S ruby anniversary

artículo científico publicado en 2008

Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy

artículo científico publicado en 2016

Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: Results from the National Cancer Data Base

artículo científico publicado en 2017

Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data base

artículo científico publicado en 2014

Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer

artículo científico publicado en 2018

Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.

artículo científico publicado en 2003

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

artículo científico publicado en 2005

Comparison of high-dose proton radiotherapy and brachytherapy in localized prostate cancer: a case-matched analysis

artículo científico publicado en 2011

Complications and Long-Term Results of Salvage Cystectomy After Failed Bladder Sparing Therapy for Muscle Invasive Bladder Cancer ⬇️

artículo científico publicado el 15 de diciembre de 2011

Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer.

artículo científico publicado en 2017

Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.

artículo científico

Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working Group

artículo científico publicado en 2013

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

artículo científico publicado en 2006

Defining recurrence after radiation for prostate cancer

artículo científico publicado en 2005

Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis

artículo científico publicado en 2005

Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.

artículo científico publicado en 2008

Does Hormone Therapy Reduce Disease Recurrence in Prostate Cancer Patients Receiving Dose-Escalated Radiation Therapy? An Analysis of Radiation Therapy Oncology Group 94-06 ⬇️

artículo científico publicado el 1 de abril de 2011

Does timing of androgen deprivation influence radiation-induced toxicity? A secondary analysis of radiation therapy oncology group protocol 9413.

artículo científico publicado en 2008

Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.

artículo científico publicado en 2014

Early Prostate Cancer: The National Results of Radiation Treatment from the Patterns of Care and Radiation Therapy Oncology Group Studies With Prospects for Improvement with Conformal Radiation and Adjuvant Androgen Deprivation ⬇️

artículo científico publicado el 1 de noviembre de 1994

Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10.

artículo científico publicado en 2006

Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial

artículo científico publicado en 2019

Effect of a short course of neoadjuvant hormonal therapy on the response to subsequent androgen suppression in prostate cancer patients with relapse after radiotherapy: a secondary analysis of the randomized protocol RTOG 86-10.

artículo científico publicado en 2002

Exploring multidisciplinary practice patterns in the management of muscle invasive bladder cancer (MIBC) across the U.S. and Canada in 2015.

scientific article published in 2016

Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based

scientific article published on 01 June 2005

Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?

artículo científico publicado en 2005

Freedom from castration: an alternative end point for men with localized prostate cancer treated by external beam radiation therapy

artículo científico publicado en 2002

Hormonal therapies: ADT for prostate cancer: true love or heartbreak?

artículo científico publicado en 2010

ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder

artículo científico

Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases ⬇️

artículo científico publicado el 27 de noviembre de 2012

Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer

artículo científico publicado en 2019

Impact of biochemical failure classification on clinical outcome: a secondary analysis of Radiation Therapy Oncology Group 9202 and 9413

artículo científico publicado en 2014

Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.

artículo científico publicado en 2015

Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995

scientific article published on 01 February 2005

Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer

artículo científico publicado en 2017

Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups

artículo científico publicado en 2006

Influence of follow-up bias on PSA failure after external beam radiotherapy for localized prostate cancer: Results from a 10-year cohort analysis ⬇️

artículo científico publicado el 1 de noviembre de 2003

Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: an analysis of patients in radiation therapy oncology group protocol 86-10.

artículo científico publicado en 2004

Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02.

artículo científico publicado en 2004

Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.

artículo científico publicado en 2009

Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233.

artículo científico publicado en 2015

Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience

artículo científico publicado en 2017

Long-term durability of PSA failure-free survival after radiotherapy for localized prostate cancer

artículo científico publicado en 2002

Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.

artículo científico publicado en 2003

Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233.

artículo científico publicado en 2014

Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience

artículo científico publicado en 2011

Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer

artículo científico publicado en 2011

Long-term results of adjuvant versus early salvage postprostatectomy radiation: A large single-institutional experience

artículo científico publicado en 2016

Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02.

artículo científico publicado en 2007

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.

artículo científico publicado en 1991

Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy

artículo científico publicado en 2009

MP26-12 INCIDENCE AND MANAGEMENT OF NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCES AFTER COMPLETE RESPONSE TO COMBINED-MODALITY ORGAN-PRESERVING THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER

artículo científico publicado en 2015

Mapping patterns of nodal metastases in seminoma: rethinking radiotherapy fields

scientific article published on 12 January 2013

MicroRNA Biomarkers for Patients With Muscle-Invasive Bladder Cancer Undergoing Selective Bladder-Sparing Trimodality Treatment

artículo científico publicado en 2018

Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer

scientific article published on 01 December 2018

Newer imaging modalities to assist with target localization in the radiation treatment of prostate cancer and possible lymph node metastases

artículo científico publicado en 2008

Nomograms Predicting Response to Therapy and Outcomes After Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer ⬇️

artículo científico publicado el 6 de marzo de 2013

Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum

artículo científico publicado en 2014

Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31.

artículo científico publicado en 2007

Old Drugs, New Purpose — Bladder Cancer Turning a Corner ⬇️

artículo científico publicado el 19 de abril de 2012

Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors

artículo científico publicado en 2003

Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma

artículo científico publicado en 2014

Overview of bladder cancer trials in the Radiation Therapy Oncology Group

artículo científico publicado en 2003

PSA bounces after neoadjuvant androgen deprivation and external beam radiation: impact on definitions of failure

artículo científico publicado en 2005

PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis

artículo científico publicado en 2005

Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer.

artículo científico publicado en 2010

Patient‐reported outcomes after 3‐dimensional conformal, intensity‐modulated, or proton beam radiotherapy for localized prostate cancer ⬇️

artículo científico publicado el 22 de febrero de 2013

Penile cancer: Clinical Practice Guidelines in Oncology

artículo científico publicado en 2013

Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemoth

artículo científico publicado en 2008

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

scientific article published on 01 March 1997

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

artículo científico publicado en 2003

Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol 92-02

artículo científico publicado en 2006

Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trial

artículo científico publicado en 2009

Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202.

artículo científico publicado en 2007

Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.

artículo científico publicado en 2008

Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer

artículo científico publicado en 2012

Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis

scientific article published on 04 December 2020

Prostate‐specific antigen response after short‐term hormone therapy plus external‐beam radiotherapy and outcome in patients treated on Radiation Therapy Oncology Group study 9413 ⬇️

artículo científico publicado el 15 de marzo de 2013

Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer.

artículo científico publicado en 2016

Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trial

artículo científico publicado en 2007

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

scientific article published on 01 May 1999

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

artículo científico publicado en 2017

Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases

scientific article published on 01 August 2002

Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer ⬇️

artículo científico publicado el 14 de julio de 2011

Radiotherapy for bladder cancer

artículo científico publicado en 2007

Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.

artículo científico publicado en 2007

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09

artículo científico publicado en 2010

Receipt of aggressive therapies for muscle-invasive bladder cancer: Results from the National Cancer Data Base.

scientific article published in 2012

Recent advances and the emerging role for chemoradiation in nonmuscle invasive bladder cancer ⬇️

artículo científico publicado el 1 de septiembre de 2013

Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial

artículo científico publicado en 2010

Reply to Saeid Safiri and Erfan Ayubi's Letter to the Editor re: Nicholas J. Giacalone, William U. Shipley, Rebecca H. Clayman, et al. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer:

artículo científico publicado en 2017

Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience

artículo científico

SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer

scientific article published on 25 January 2019

Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors

artículo científico publicado en 2002

Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates--the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences

artículo científico publicado en 2005

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial

artículo científico publicado en 2018

Surgery: selective bladder-preserving therapy for muscle-invasive cancer

scientific article published on 01 April 2009

Survivin is a potential mediator of prostate cancer metastasis

artículo científico publicado en 2010

T1 high-grade bladder cancer recurring after BCG therapy: a curative alternative to radical cystectomy exists. Con

Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer

artículo científico publicado en 2008

The impact of MRE11 in nuclear to cytoplasmic ratio on outcomes in muscle invasive bladder cancer an analysis of NRG/RTOG 8802, 8903, 9506, 9706, 9906, and 0233.

scientific article published in 2017

The importance of combined radiation and endocrine therapy in locally advanced prostate cancer ⬇️

artículo científico publicado el 26 de diciembre de 2011

The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92-02.

artículo científico publicado en 2009

The opportunity cost of androgen suppression in locally advanced prostate cancer ⬇️

artículo científico publicado el 25 de febrero de 2013

The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?

artículo científico publicado en 2008

The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995.

artículo científico publicado en 2010

Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre

artículo científico publicado el 1 de julio de 2013

Trimodality Therapy for Bladder Conservation in Treatment of Invasive Bladder Cancer ⬇️

artículo científico publicado el 1 de abril de 2013

Trimodality bladder preservation therapy for muscle-invasive bladder cancer

artículo científico publicado en 2013

Urological cancer. The benefits of intermittent androgen-deprivation therapy

artículo científico publicado en 2012

Use of Potentially Curative Therapies for Muscle-invasive Bladder Cancer in the United States: Results from the National Cancer Data Base ⬇️

artículo científico publicado el 19 de noviembre de 2012

Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer

artículo científico publicado en 2008

Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial.

artículo científico publicado en 2006

Words of Wisdom. Re: Radical Cystectomy vs. Chemoradiation in T2-4aN0M0 Bladder Cancer: A Case-control Study

artículo científico publicado en 2016

Words of wisdom. Re: Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer.

artículo científico publicado en 2013

Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era

artículo científico publicado en 2005

coucou

artículo científico publicado en 2003

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda